Maplight Therapeutics Inc (MPLT) 13F Holders & Ownership Data (109 Funds, Q2 2026)

MPLT ranks #4392 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

MPLT is a top-conviction position for Nan Fung Group Holdings Ltd — at 26.5% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in MPLT belongs to Novo Holdings A/S, but the position matters far more to Nan Fung Group Holdings Ltd, who has 26.5% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Novo Holdings A/S has added to its MPLT position for two straight quarters, increasing it by $67.4M to reach $132.1M today.

Lazard Asset Management LLC has trimmed its MPLT position for two straight quarters, cutting it by $774.5K while still holding $2.9M.

MPLT is down 1.9% today, but institutions show net buying of $100.6M this quarter — a divergence between today's price move and the underlying institutional flow.

MPLT reported a net loss of $161.2M in its latest fiscal year.

• Not yet profitable — net loss of $161.2M in the latest fiscal year
• Net income declined year over year, from -$77.6M to -$161.2M
• Operating cash flow was negative, using $138.1M in cash
• Current ratio of 20.01x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.05x equity — within a conventional range